New insights into pre-BCR and BCR signalling with relevance to B cell malignancies

RC Rickert - Nature Reviews Immunology, 2013 - nature.com
The B cell receptor (BCR) and its precursor (pre-BCR) control B cell homeostasis,
differentiation and function. Moreover, aberrant pre-BCR and BCR signalling have a central …

Single-cell mass cytometry for analysis of immune system functional states

ZB Bjornson, GP Nolan, WJ Fantl - Current opinion in immunology, 2013 - Elsevier
Highlights•Quantitative measurements of 40 proteins or mRNA species per cell.•Antibodies
labeled with isotopes instead of fluorophores.•Deep cell profiling of functional network …

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies

RH Advani, JJ Buggy, JP Sharman… - Journal of Clinical …, 2013 - ascopubs.org
Purpose Survival and progression of mature B-cell malignancies depend on signals from the
B-cell antigen receptor, and Bruton tyrosine kinase (BTK) is a critical signaling kinase in this …

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

JW Friedberg, J Sharman… - Blood, The Journal …, 2010 - ashpublications.org
Certain malignant B cells rely on B-cell receptor (BCR)–mediated survival signals. Spleen
tyrosine kinase (Syk) initiates and amplifies the BCR signal. In in vivo analyses of B-cell …

Bruton tyrosine kinase (BTK) and its role in B-cell malignancy

JJ Buggy, L Elias - International reviews of immunology, 2012 - Taylor & Francis
BTK is a kinase that functions downstream of multiple receptors in various hematologic cells.
This review focuses on BTK-dependent pathways that are likely to be involved in …

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

L Chen, S Monti, P Juszczynski, J Daley… - Blood, The Journal …, 2008 - ashpublications.org
The role of B-cell receptor (BCR)–mediated survival signals in diffuse large B-cell lymphoma
(DLBCL) remains undefined. Ligand-induced BCR signaling induces receptor …

The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells

BY Chang, MM Huang, M Francesco, J Chen… - Arthritis research & …, 2011 - Springer
Introduction The aim was to determine the effect of the Bruton tyrosine kinase (Btk)-selective
inhibitor PCI-32765, currently in Phase I/II studies in lymphoma trials, in arthritis and immune …

[HTML][HTML] Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer

MO Krisenko, RL Geahlen - … et Biophysica Acta (BBA)-Molecular Cell …, 2015 - Elsevier
SYK (spleen tyrosine kinase) is well-characterized in the immune system as an essential
enzyme required for signaling through multiple classes of immune recognition receptors. As …

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

S Cheng, J Ma, A Guo, P Lu, JP Leonard, M Coleman… - Leukemia, 2014 - nature.com
Bruton agammaglobulinemia tyrosine kinase (BTK), a cytoplasmic protein tyrosine kinase, is
a component of the B-cell receptor signaling pathway. Ibrutinib, a BTK inhibitor, has …

Transformation of indolent B-cell lymphomas

S Montoto, J Fitzgibbon - Journal of clinical oncology, 2011 - ascopubs.org
Histologic transformation (HT) to an aggressive lymphoma is a well-described event in the
natural history and clinical course of patients with so-called indolent lymphomas. This …